Concepedia
Statistics
Publications
80
Citations
8.6K
H-Index
39
Active since
1990
Affiliations
The Ohio State University(Current)
University of Bath
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
The Ohio State University Wexner Medical Center
Pharmacyclics (United States)
Joseph M. Flynn is an author at The Ohio State University specializing in medicine, oncology, and immunology.
Top concepts
MedicineOncologyImmunologyCancer ResearchHematologyPharmacotherapyPathologyPharmacologyImmunotherapyHealth
Publications per year
1990–2021
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman, Amber Gordon, Erin Hertlein et al. · Blood · 2011 · 789 citations · Full text
Invited review article: Strategies and processes for high quality wire arc additive manufacturing
Chloe Cunningham, Joseph M. Flynn, Alborz Shokrani et al. · Additive manufacturing · 2018 · 785 citations
Materials Science, Review Article, Engineering +7
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 783 citations · Full text
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
Kami J. Maddocks, Amy S. Ruppert, Gerard Lozanski et al. · JAMA Oncology · 2015 · 568 citations · Full text
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E.M. Herman, Amber Gordon, Amy J. Wagner et al. · Blood · 2010 · 541 citations · Full text
Rows per page
1–5 of 80